O'Shaughnessy MV - Search Results

1

High pregnancy rates and reproductive health indicators among female injection-drug users in Vancouver, Canada.

Weber AE, Tyndall MW, Spittal PM, Li K, Coulter S, O'Shaughnessy MV, Schechter MT. Weber AE, et al. Eur J Contracept Reprod Health Care. 2003 Mar;8(1):52-8. Eur J Contracept Reprod Health Care. 2003. PMID: 12725675

2

Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme.

Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Wood E, et al. AIDS. 2002 Apr 12;16(6):941-3. doi: 10.1097/00002030-200204120-00021. AIDS. 2002. PMID: 11919503

3

Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.

Spittal PM, Craib KJ, Wood E, Laliberté N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Spittal PM, et al. CMAJ. 2002 Apr 2;166(7):894-9. CMAJ. 2002. PMID: 11949985 Free PMC article.

4

Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs.

Miller CL, Spittal PM, LaLiberte N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Miller CL, et al. J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):335-41. doi: 10.1097/00126334-200207010-00010. J Acquir Immune Defic Syndr. 2002. PMID: 12131571

5

Satellite needle distribution among injection drug users: policy and practice in two canadian cities.

Tyndall MW, Bruneau J, Brogly S, Spittal P, O'Shaughnessy MV, Schechter MT. Tyndall MW, et al. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):98-105. doi: 10.1097/00126334-200209010-00013. J Acquir Immune Defic Syndr. 2002. PMID: 12352156

6

The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT. Wood E, et al. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8. doi: 10.1097/00126334-200301010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12514408

7

Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.

Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, Heath K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Craib KJ, et al. CMAJ. 2003 Jan 7;168(1):19-24. CMAJ. 2003. PMID: 12515780 Free PMC article.

8

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.

Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, Schechter MT. Tyndall MW, et al. AIDS. 2003 Apr 11;17(6):887-93. doi: 10.1097/00002030-200304110-00014. AIDS. 2003. PMID: 12660536

9

Sexual violence among a cohort of injection drug users.

Braitstein P, Li K, Tyndall M, Spittal P, O'Shaughnessy MV, Schilder A, Johnston C, Hogg RS, Schechter MT. Braitstein P, et al. Soc Sci Med. 2003 Aug;57(3):561-9. doi: 10.1016/s0277-9536(02)00403-3. Soc Sci Med. 2003. PMID: 12791497

10

An external evaluation of a peer-run "unsanctioned" syringe exchange program.

Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O'Shaughnessy MV, Schechter MT. Wood E, et al. J Urban Health. 2003 Sep;80(3):455-64. doi: 10.1093/jurban/jtg052. J Urban Health. 2003. PMID: 12930883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters